Healthcare
Redcare Pharmacy N.V.(SHPPF)
Live Price
Offline$64.80
+0.00% today
1Y Change
-56.28%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $980.00M
- Revenue Growth
- +24.0%
- EPS Growth
- +17.3%
- Dividend Yield
- 0.0%
Coverage: 253 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Redcare Pharmacy N.V. (SHPPF) is a Healthcare stock with a market cap of $980.00M and listed on OTC. The stock last traded around $64.80 and down 56.3% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +24.0%, EPS growth of +17.3%, a dividend yield of 0.0%. What stands out right now is revenue +24.0%, EPS +17.3%, free cash flow -181.0% with operating margin -1.0% and ROIC -2.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SHPPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+24.0% vs +7.6% peer median
Operating Margin
Below sector median
-1.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +24.0% and EPS at +17.3%, with operating margin around -1.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -12.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Mar 4, 2026 | -185.6% | +0.0% | -14.5% | -20.7% |
2025 Oct 29, 2025 | -13.8% | +0.0% | -21.4% | -21.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHPPF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SHPPF Max Drawdown
-69.52%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SHPPF and SPY.
Company Overview
Redcare Pharmacy N.V.
Other OTC
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
- Leadership
- Olaf Heinrich
- IPO Date
- Jan 6, 2021
- Employees
- 1.8k
- Street Address
- Erik de Rodeweg 11โ13
- Mailing
- Sevenum, 5975 WD
- Region
- Sevenum, NL
- Reporting Currency
- USD
- Investor Line
- 800 200 800 300
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 19.9
- Price/Sales
- 0.3
- Price/Book
- 2.1
Growth
- Revenue
- +24.0%
- EPS
- +17.3%
- Free Cash Flow
- -181.0%
Profitability
- Gross Margin
- 21.7%
- Operating Margin
- -1.0%
- Net Margin
- -1.3%
- ROE
- -7.8%
- ROIC
- -2.5%
Balance Sheet
- Debt/Equity
- 0.91
- Current Ratio
- 1.55
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.